The efficacy of CRISPR-Cas9 is heavily dependent on the efficiency of its delivery into target cells. Effective delivery systems ensure that the CRISPR components reach the desired location within the body, maintain their functionality, and minimize off-target effects. This is where nanotechnology comes into play.
